O'Connor John James 4

What Happened

• John James O'Connor, a director of Lemaitre Vascular, received dividend-equivalent rights that accrue on existing restricted stock unit (RSU) and performance share unit (PSU) awards. On 2026-03-26 he was credited five derivative amounts totaling 3.445 shares (0.394, 0.472, 0.643, 0.728 and 1.208); each was reported at $0.00 per share (derivative awards, not open-market purchases).

Key Details

• Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (timely — within two business days).
• Price: $0.00 per share (these are dividend-equivalent rights, reported as derivative awards).
• Total reported derivative amount: 3.445 shares across five entries.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1–F5 indicate these are dividend equivalent rights that accrued on prior awards (RSUs and PSUs granted 12/8/2023, 12/6/2024, and 12/10/2025) and vest proportionately; each right is the economic equivalent of one common share.
• No 10b5-1, tax-withholding, or cash sale activity was disclosed in this filing.

Context

• These entries reflect dividend-equivalent accruals on existing equity awards — a bookkeeping/compensation event rather than a market buy or sell. Such derivative credits typically convert to shares (or cash) only as the underlying RSUs/PSUs vest; they do not by themselves indicate a purchase or sale decision by the insider.